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Abstract 
Aim: The aim of this paper is to present the findings of an integrative literature review of the 
evidence for the clinical management of delirium in patients with advanced cancer. 
Background: Patients with advanced cancer frequently experience delirium which can be distressing 
for both patients and their families. Current guidelines recommend that underlying causes of the 
delirium be addressed and a course of antipsychotics considered.  However the research into the 
effectiveness of treatments for delirium in people with advanced cancer is limited.  
Design: Integrative literature review 
Data sources: Systematic searches of the MEDLINE, CINAHL, ProQuest Nursing and Allied Health 
and PsychInfo databases were conducted in April 2016 to include papers published in 2000 and later. 
The returns were screened using inclusion and exclusion criteria and the seven studies found to be 
suitable were subject to review.  
Review Methods: Findings of the seven papers were extracted, appraised critically and reviewed 
using a  narrative approach.  
Results: A number of interventions, including the use of atypical antipsychotics, opioid rotation, 
methylphenidate hydrochloride and  celiac plexus block were reported however there was limited 
evidence of their effectiveness.  One study reported the use of exercise therapy as a non-
pharmacological intervention. 
Conclusion: A variety of interventions to treat delirium in patients with advanced cancer have been 
tested through non-blinded, non-randomised trials which has not produced a clear evidence-base for 
practice.  There is a need for further research (particularly randomised control trials) to determine the 
most effective treatments for patients with advanced cancer experiencing delirium. 
 
Key Words: literature review, delirium, palliative care, end of life, advanced cancer, 
neoplasm, management, nursing.   
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What does this paper contribute to the wider global clinical community? 
Why is this review needed?  
• There is a lack of evidence to inform the management of delirium in patients with 
advanced cancer.  .  
• The lack of evidence for the management of delirium in patients with advanced 
cancer means that patients, their families and carers, may not be receiving the most 
appropriate care.  
Key Findings:  
• Available research on the clinical management of delirium in advanced cancer is 
limited and of variable quality. 
• A number of pharmacological and non-pharmacological interventions have been used 
to treat delirium in patients with advanced cancer however the evidence base for 
practice is limited.  
How should these findings be used?  
• These findings highlight the need for further investigation of the  treatment of 
delirium in advanced cancer. 
• Provide insights for nurses and other professionals on the effectiveness of the 
treatments currently in use.   
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The Review 
Introduction  
Patients with advanced cancer often experience delirium, yet strategies for its early detection, 
prevention, and management are limited (Caraceni and Simonetti 2009).  Delirium is one of 
the most difficult syndromes to diagnose and treat and has an adverse impact on the quality of 
life for the patient and their family in the final days of life (Centeno et al 2004).  There are 
various definitions of advanced cancer, however for the purpose of this paper, advanced 
cancer is that which cannot be cured and is likely to cause death (American Cancer Society, 
2014).  This means that End of Life concerns, such as preferred place of death, are real and 
valid for those diagnosed with advanced cancer.  For example, although most people would 
prefer to die at home rather than in hospital (National Audit Office, 2008), delirium can result 
in longer hospital stays (Ljubisavljevic and Kelly, 2003), meaning patients may not be able to 
die in their preferred place. Moreover family members and carers generally provide the most 
care for their loved ones experiencing delirium which causes distress (Namba et al, 2007), 
which is often exacerbated as delirious patients are more likely to be non-compliant and risk 
putting themselves or others in danger (for example by pulling out IV lines/catheters) and 
being aggressive. 
In view of this a need to examine the evidence for the clinical management of delirium in 
patients with advanced cancer was identified, in order to determine how it can be best 
managed.  The aim of this review was to examine evidence for pharmacological and non-
pharmacological treatments for delirium in patients with advanced cancer to determine the 
evidence base for practice and to highlight gaps in knowledge  
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Background  
One of the most challenging aspects of end of life care, and a reason why many patients stay 
in and die hospital, is poor symptom control.  Effective amelioration of symptoms including 
delirium, pain and nausea can help a patient to have a ‘good death’ (de Jong and Clarke, 
2009).  Although guidelines exist for the general and more specific management of delirium 
in cancer patients (NICE 2015, CCO 2010, Western Australia Cancer & Palliative Care 
Network 2010), the guidance concerning treatment in patients with advanced cancer is 
limited, in part because of  the limited evidence available. The treatment and medication 
patients may receive as part of their cancer treatment can mean the standard approach to 
treating delirium is less effective.   
Delirium is defined as a neurocognitive disorder characterised by a disturbance in attention 
and cognition, which can result from another medical condition (or from multiple aetiologies) 
for example pyrexia and malnutrition. The condition develops over a short period of time and 
cannot be explained by any another neurocognitive disorder (Diagnostic and Statistical 
Manual of Mental Disorders - V, 2013).  Delirium can manifest in a number of ways (see 
table 1) and in practice, it is often nurses who recognise the symptoms when they first 
present. A variety of tools exist which can be used to help identify and diagnose the 
condition. For example the National Institute for Health and Care Excellence (NICE 2010) 
recommends the use of the Diagnostic and Statistical Manual of Mental Disorders – IV 
(DSM-IV) criteria or the Confusion Assessment Method (CAM), although other tools 
including the MDAS (Memorial Delirium Assessment Scale) and the MMSE (Mini-Mental 
State Examination) are available and often used in screening.  Despite the availability of 
these tools however, the rate of detection of delirium in patients in practice is low. Ryan et al, 
2013 found that nurses identified 63.6% of patients with delirium as confused or delirious, 
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however only 43.6% of those patients had the observation they were confused recorded in 
their notes. In a study of patents with advanced cancer it was found that the overall detection 
rate in patients with terminal cancer by any member of the palliative team was 44.9% and the 
detection rate of the hypoactive subtype was only 20.5%, significantly lower than that of the 
hyperactive/mixed subtypes (see below) (Fang et al 2008).  
(Table 1 here) 
Although the term delirium is widely used, there are distinct subtypes of delirium which are 
based on their clinical presentation. They are:  hyperactive, hypoactive and mixed, and 
delirium with catatonic symptoms.  For example, a comparison of symptoms of delirium in a 
range of patients found that 50.15% had the hyperactive subtype, 24.61% the mixed subtype 
and 19.93% the hypoactive subtype (Grover et al 2014).  In other studies, the mixed type of 
delirium was most common (Peterson et al 2006; Kim et al 2015). Patients with hyperactive 
delirium are often restless, agitated and hyper-vigilant and experience perceptual disturbances 
and delusions, whereas patients with hypoactive delirium demonstrate lethargy and minimal 
spontaneous movement (Fang et al, 2009; Grover et al, 2014).  The identification of different 
subtypes raises the issue of whether they should be treated as separate conditions, especially 
noting that patients experiencing hypoactive and mixed types of delirium have a poorer 
prognosis than those with hyperactive delirium (Kim et al, 2015), suggesting different 
treatment approaches may be needed.   
Estimates for total cancer deaths in 2012 were 8.2 million (about 22,000 cancer deaths a day), 
and by 2030 the global burden is expected to grow to 21.7 million new cancer cases and 13 
million cancer deaths (American Cancer Society 2015).   The prevalence of delirium in 
patients with terminal cancer ranges from 28% to 85% (Minagawa et al 1996; de la Cruz et 
al, 2015; Massie et al 1983).  This large variation may be a result of the difficulties involved 
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in accurately identifying the symptoms of the different subtypes of delirium (particularly 
hypoactive delirium), misdiagnosis, or a lack of the training staff need to make an 
assessment. Patients with cancer are at particular risk of developing delirium for a number of 
reasons, including exposure to certain drugs (opioids, corticosteroids, and benzodiazepines) 
(Gaudreau, 2005), and the presence of bone metastases and haematological malignancies 
(Ljubisavljevic and Kelly, 2003).  In a recent literature review it was concluded that there 
needs to be a greater understanding of delirium in palliative care, including its 
pathophysiology and causation, as well as its treatment (Grassi et al 2015).   
 
Current Clinical Management 
Current approaches to the care of people with delirium involve non-pharmacological and 
pharmacological management.  Non-pharmacological interventions are recommended such as  
nurses ensuring there is a clock visible in clinical areas and explaining to patients where they 
are and introducing themselves and other staff members, helping to keep patients orientated 
to time and place (NICE, 2010). Preventing precipitating factors such as constipation and 
dehydration can also help (NICE 2010), and this entails nursing staff planning care to ensure 
patients are mobilised, encouraged to drink and that bowel movements are monitored.  
Pharmacologically, the recommended initial treatment is a short term, low dose course of 
haloperidol or olanzapine.  Hui et al (2010) for example found olanzapine was given to 17% 
of delirious patients and haloperidol to 72% of the patients, perhaps reflecting the evidence 
that Haloperidol has been shown to reduce symptoms of delirium in patients with cancer with 
no significant side effects (Akechi et al 1996).  Delirium is also one of the most common 
reasons patients with advanced cancer are prescribed  sedation (Alonso-Babarro et al, 2010; 
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Beller et al, 2014), which has been criticised on the basis that its use should be decided on an 
individual basis (National Ethics Committee, Veterans Health Administration, 2007). 
The management of delirium requires an interdisciplinary approach (Milisen et al, 2001; 
Meagher, 2001) with nurses holding a key role in its prevention, detection and management 
(Siddiqi et al 2006), as they are at the front line of care and provide the majority of screening 
on admission to hospital.  Tools available for nurses to use to identify the presence of 
delirium include the Mini-Mental State Exam (MMSE) which is comprised of five sections 
assessing orientation, registration, attention, recall and language. Its use has been effective in 
detecting delirium and as a diagnostic aid (Anthony 1982; Faught 2014).  On the basis of the 
outcome nurses can refer patients to the appropriate healthcare professionals for further 
assessment and treatment.  
 
Despite the increasing amount of research into delirium experienced at the end of life in the 
past decade (Close and Long, 2012; Harris, 2007), there are very few studies that focus on the 
treatment of delirium in patients with advanced cancer.,  A review of the evidence exploring 
the management of delirium in patients post-surgery and those being cared for in intensive 
care settings, found delirium can be improved in around half of patients by removing 
precipitating factors (Kang et al 2013).  Although this highlights some useful evidence for 
practice, the study did not specifically address the needs of patients with advanced cancer, 
where it is often not possible to eliminate some of the precipitating factors identified.  
Patients who are at the end of their life as a result of advanced cancer are often receiving 
chemotherapy and opioid pain relief, which may mean the delirium experienced and the 
treatment for that delirium is different to that experienced by patients  who do not have 
advanced cancer.  
 
Page 8 of 35
Journal of Clinical Nursing
Journal of Clinical Nursing
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
[Type text] 
 
9 
 
Design  
The design of this study is an integrative literature review. The purpose of nursing research is 
to solve problems or answer questions that are relevant to nursing practice (Polit and Beck, 
2014).  The clinical management of delirium in patients with advanced cancer is one such 
problem.  Although it is a common phenomenon (Minagawa et al 1996; de la Cruz et al, 
2015; Massie et al 1983), there is little guidance in practice concerning how best to manage 
it.  The review question was developed using the Population, Intervention and Outcome 
elements of the PICO model (Polit and Beck, 2014).  This was used to guide the development 
of the question and because the focus was on studies reporting any intervention to alleviate 
delirium in patients with advanced cancer the C (comparator) element was not required. This 
process is summarised in Table 2. 
(Table 2 here) 
 
An initial search revealed there was little research reporting the treatment of delirium in 
patients with advanced cancer.  Consequently although a systematic review is generally the 
recommended approach (Cullinan, 2005), it was not appropriate for this question because of 
the variety of interventions explored in the relevant literature. In view of this an integrative 
review was undertaken.  In contrast to a systematic reviews, which aim to systematically 
search for, appraise and synthesise research evidence, aiming for exhaustive and 
comprehensive searching (Grant and Booth, 2009) and adhere to a strict design based on 
explicit, pre-specified, and reproducible methods (Gopalakrishnan and  Ganeshkumar 2013) 
and generally focus on randomised controlled trials (Akenborg 2005), in an integrative of 
review, studies using diverse methodologies can be included and the approach has the 
potential to play a greater role in evidence-based practice for nursing (Whittemore and Knafl 
2005). It is a review method which summarises previous empirical or theoretical literature, to 
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provide a more comprehensive understanding of a healthcare problem (Broome 1993 [cited in 
Whittemore and Knafl, 2005]). The primary sources included in an  integrative review need 
to be logically grouped to facilitate analysis (Whittemore and Knafl, 2005). Ryan (2013) 
recommends that the similarities and differences of the findings of different studies and 
patterns in the data should be explored and in the review reported here there were 
interventions that could be considered together.  
 
Search Methods 
Four databases; MEDLINE, CINAHL, ProQuest Nursing and Allied Health and PsychInfo 
were searched because they were likely to include sources addressing the review question as 
they focus on medicine, nursing and psychology. The searches were conducted  in April 2016 
to include papers published in 2000 and later. Table 3 identifies the search terms used.  The 
search terms were derived from the research question and the databases were searched using 
those key words or phrases identified. Boolean operators (AND, OR, NOT) were used to 
further refine the search. A ‘wildcard’ was also used, which allows multiple words to be 
searched for which have the same truncation, for example ‘deliri*’ would return results for 
‘delirium’ and ‘delirious’ (Aveyard, 2010).  One article was found through hand-searching 
through the reference lists of relevant articles (Horsely et al, 2001).  Papers were excluded if 
they were unavailable in English, but not if they were conducted in other countries and 
reported in English. The inclusion and exclusion criteria used to determine the selection of 
papers for review are shown in Table 4.  
(Table 3 here) 
(Table 4 here). 
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Search Outcomes 
 
The results of the screening process are shown in the PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses) in figure 1 below. The selection of the papers for 
inclusion in the review was made following independent review of titles and abstracts by both 
authors. Titles and abstracts were identified by the systematic search of the databases noted 
earlier, guided by the application inclusion and exclusion criteria (Table 4). Papers found not 
to be relevant to the aims of study by their titles and abstracts were excluded. The full text 
versions of the twenty seven papers which met the inclusion criteria were obtained and read. 
On the basis of this second stage of independent review seven were found to be suitable for 
full critical review (see figure 1). 
(Figure 1 here) 
Data Abstraction  
All the articles retrieved were read several times by one author and reviewed by the second 
author to gain a deeper understanding of the studies.  A data abstraction form was used to 
record the key content of each paper in preparation for analysis (Polit and Beck, 2014).  The 
design, aim sample, tool, results, limitations identified and recommendations made in the 
papers are summarised in table 5.   
 
(Table 5 here) 
 
Summary of the Studies included  
Arai at al, 2013: This prospective study investigated terminal delirium in patients with 
pancreatic cancer and found that those who underwent a celiac plexus block had terminal 
delirium for a shorter time than those who did not.   
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Boettger and Breitbart, 2011: An open label naturally assigned study of patients with cancer 
(46.7% had advanced cancer) that investigated whether aripiprazole could be used to treat 
delirium. It found  that aripiprazole may be safe and effective in treating delirium.   
Moryl et al, 2005: Investigated ‘switching’ to methadone as part of an opioid rotation strategy 
in patients with advanced cancer and found that methadone may be considered in treating 
terminal delirium before the introduction of sedation.  
Morita et al, 2005: Examined opioid rotation (morphine to fentanyl) in patients with cancer 
receiving palliative care who were experiencing morphine induced delirium, and found that 
the switch to fentanyl may alleviate the delirium.  
Tatematsu et al, 2011: Investigated exercise therapy as an approach  to reducing delirium in 
patients with cancer and found that the antipsychotic dose was lower in those in who received 
exercise therapy concluding that exercise therapy had potetntial  as a non-pharmacological 
intervention for the management of delirium. 
Gagnon et al, 2005: Investigated the use of methylphenidate in treating hypoactive delirium 
in patients with advanced cancer, finding that hypoactive delirium with no known aetiology 
may be improved by prescribing methylphenidate.  
Breitbart et al, 2002: Demonstrated  the efficacy and safety of olanzapine for use in the 
management of delirium patients with cancer in  hospital.  
 
Critical Appraisal  
The articles were then subjected to critical appraisal which involved assessing the strengths 
and weaknesses of the selected papers in order to assess their relevance to the review 
question (Aveyard, 2010).  The papers were reviewed to assess trustworthiness and quality 
using a set of recognised criteria (Mhaskar et al, 2009; Polit and Beck, 2014).  The 
critical  appraisal of the papers involved the use of a tool designed to assess the quality of 
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studies employing a quantitative design (Hek and Moule 2006), supplemented with key 
questions developed by Polit and Beck (2014).  These were combined in an appraisal form 
which can been seen in figure 2. 
(Figure 2 here).  
 
The appraisal of the specific statistical tests used in the studies can be seen in table 6 (seen in the 
statistical analysis section below), and the overall quality ratings of the papers resulting from the 
application of the appraisal tool in figure 2 can be found in table 7. 
(Table 7 here)  
 
Synthesis 
There is a lack of research which investigates delirium experienced by patients with advanced 
cancer and that which exists is of variable quality.  No randomised control trials of 
interventions developed to treat delirium could be located.  The review of the 7 articles 
suitable for inclusion demonstrated that a range of pharmacological and non-pharmacological 
interventions have been explored.  It was not possible to combine and analyse the results 
using statistics because the papers investigated the use of different interventions using 
different methods.  In view of this, the results are grouped on the basis of the main findings as 
a basis for further discussion of their implications. The common main findings were 
identified by reading through the included studies, identifying the types of interventions that 
were used and considering the implications of these approaches.  The interventions identified 
were use of: atypical antipsychotics, opioid rotation, other pharmacological interventions and 
non-pharmacological interventions.  However before considering these further,  a number of 
general points about the studies are presented below. 
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Results 
Design 
All of the studies lacked the rigour of RCTs, as they were open-label, non-blinded and non-
randomised (Sedgwick 2014), although most did report statistically significant results (apart 
from Moryl et al, 2005 which does not include any statistical analysis). All of the studies 
excepting  Tatematsu et al (2011) were prospective in nature.  
Sampling 
The studies all used purposive sampling, a technique often used in qualitative research, where 
researchers select participants who can best address the purpose of the study (Aveyard, 
2010).  This type of sampling can introduce bias because of the absence of randomisation 
(Clifford, 1997).  However in the studies reviewed here, the sample characteristics were so 
specific that it may have been difficult to recruit the patients in any other way.  Excepting 
Breitbart et al (2002) sample sizes were less than 30 (the 2010 study by Tatematsu used 31 
patients for the control group and 17 for the intervention group) which affects the statistical 
significance of the findings (Krithikadatta, 2014).  Power calculations to determine the 
sample size required to test their hypothesis (Polit and Beck, 2014), were not carried out, (or 
were not reported on), in the seven studies. 
Tools  
A number of tools were used to collect data about the presence and severity of delirium.  The 
MDAS was the commonest (Boettger and Breitbart 2011, Moryl et al 2005, Breitbart et al 
2002).  The Japanese version, which omits some the original items, was used by Morita et al 
(2005).  The CAM, DOS and MMSE were used in other studies (Tatematsu et al 2011; Arai 
et al 2013; Gagnon et al 2005).  The use of different tools means identification of delirium 
varied between the studies.  Those using MDAS applied different thresholds for the definition 
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of delirium, for example Breitbart et al (2002), Boettger and Breitbart (2011) and Morita et al 
(2005) considered an MDAS < 10 to indicate delirium resolution, whereas a score of less 
than 13 is generally accepted as accurate (Alici and Breitbart, n.d). 
Statistical Analysis  
All of the papers include statistical analysis of the results (producing inferential statistics) 
apart from Moryl et al (2005), which includes descriptive statistics. The statistical test used 
depends on the type of data, whether it is parametric or non-parametric, and then the type of 
data generated; nominal, ordinal, interval or ratio.  Parametric data follows a normal 
distribution (usually a sample of 30 or more is required for this) and non-parametric data does 
not follow normal distribution (Krithikadatta, 2014).  A variety of statistical tests were used 
to analyse the data. Table 6 summarises the tests used and their appropriateness for the type 
of data they were analysing (Institute for Digital Research and Education, n.d.).  
(Table 6 here) 
Main Treatment Approaches 
Atypical Antipsychotics   
The use of atypical antipsychotics was explored in two of the papers, olanzapine (Breitbart et 
al 2002) and aripiprazole (Boettger and Breitbart 2011).  Both  report statistically significant 
results, with Boettger and Breitbart (2011) recording the mean MDAS at T1 was 18.0 which 
reduced to a mean MDAS at a stable dose of aripiprazole at T3 of 8.3 (p <0.001).  Breitbart et 
al (2002) found 76% of the patients had resolution of their delirium at T3  based on an 
MDAS of < 10, meaning the MDAS score improved from 19.85 (± 3.79) to 10.78 (± 7.31), P 
= 0.001.  The statistical significance of these findings needs to be treated with caution 
because of the open-label non-randomised study designs.  For example Breitbart et al (2002) 
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analysed confounding factors and found that treatment outcome was affected by designation 
of the delirium subtype.  This suggests that the management of subtypes could be different.  
Opioid Rotation  
Two studies explored opioid rotation in the management of delirium.  The change to 
Methadone for patients with morphine induced delirium (Moryl et al, 2005), and the 
replacement of morphine with Fentanyl (Morita et al, 2005).  Moryl et al (2005) found 
‘average’ MDAS improved from 23.6 to 10.6, but it is not specified if this is referring to the 
mean, mode, or median.  When Fentanyl was introduced the mean MDAS decreased from 14 
at T1 to 3.6 at T3 (p < 0.001) (Morita et al 2005).  However, the tool used to collect this data 
was the Japanese version of the MDAS, with some of the original items excluded, so again 
the results need to be regarded with caution.   
 
Other Pharmacological Interventions 
Two studies reporting other pharmacological interventions were located.  The first 
investigated the use of a Celiac Plexus Block (CPB), and it was  found that the duration of 
Terminal Delirium (TD) was lower in the CPB group  than the control group (1.8 ± 2.9 vs 
10.4 ± 7.5 days respectively) (Arai et al, 2013).  In the second  Methylphenidate 
hydrochloride (Gagnon et al 2005) was prescribed for patients with hypoactive delirium 
resulting in an improvement from 20.9 ± 4.9 pre-treatment to 27.8 ± 2.4 on the MMSE when 
the patients were on a stable dose of methylphenidate (Gagnon et al 2005).  Its use for the 
treatment of hypoactive delirium in the study limits its generalisability to other forms of 
delirium.     
Non-Pharmacological Intervention  
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The only report of a non-pharmacological intervention located, investigated the use of 
exercise therapy (Tatematsu et al, 2011).  It found that antipsychotic dose was lower in the 
experimental group (2.198mg) than the control group (5.533mg) (P < 0.036),however the 
sample size was too small for the results to be generalizable.  This study indicates there may 
be potential in non-pharmacological interventions as a wider range of staff would be able to 
deliver them. 
Discussion 
The findings of the research demonstrate that although there has been some investigation of 
the treatment of delirium in patients with advanced cancer, relatively few rigorous studies 
have been conducted.  In terms of pharmacological interventions, the use of atypical 
antipsychotics reduced mean MDAS scores (Boettger and Breitbart, 2011; Breitbart et al, 
2002), as did opioid rotation (Moryl et al, 2005 and Morita et al, 2005), a celiac plexus block 
reduced the duration of terminal delirium (Arai et al, 2013), and methylphenidate was found 
to be effective in patients with hypoactive delirium (Gagon et al, 2005).  The one report of a 
non-pharmacological intervention found that the dose of antipsychotics could be reduced for 
patients participating in exercise therapy (Tatematsu et al, 2011).  
The findings of this literature review are inconclusive in terms of identifying a single safe and 
effective treatment for delirium experienced by patients with advanced cancer.  Haloperidol 
is often the first line treatment for delirium (NICE, 2010), however, a conference paper 
identified in the literature search reported that haloperidol alone was  insufficient to control 
delirium in patients with advanced cancer because while 128 of the 167 patients required therapy 
with only haloperidol, 39 required a second neuroleptic to control symptoms (Susman, 2014).  
Another first line treatment for delirium is olanzapine, which Breitbart et al (2002) 
investigated and even though the rigour of the study is not comparable with an RCT, the 
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results were still deemed to be significant. The use of aripiprazole has not been explored to a 
great extent although small studies such as the one by Boettger and Breitbart (2011)  indicate 
it has helped resolve delirium.  Further work is needed to determine if it can be added to the 
drugs licenced to treat delirium.   
The substitution of one opioid for another can improve therapeutic response and/or reduce 
side effects (Moryl et al 2005; Morita et al 2005; Knotkova et al, 2009).  Cancer patients 
often experience pain and are prescribed opioids for pain relief even though this increases the 
risk of delirium (Gaudreau et al, 2007; Morrison et al 2003).  Further investigation of the 
effects of opioid rotation is important for the treatment of delirium in patients with advanced 
cancer.  The final pharmacological intervention studied was the use of methylphenidate 
hydrochloride in patients with hypoactive delirium (Gagnon et al, 2005).  Methylphenidate is 
licenced to treat attention-deficit hyperactivity disorder (ADHD) (BNF, 2014).  It works by 
increasing the amount of dopamine available in areas of the brain responsible for reward and 
motivation (Volkow et al, 2012) and causes a 'calming' effect on patients with ADHD.  
Because the pathophysiology of delirium is still not fully understood (Bush and Bruera 2009), 
it is not clear how methylphenidate works to improve symptoms.  This suggests further trials 
of this agent would be of value. 
The one non-pharmacological intervention studied was exercise therapy (Tatematsu et al, 
2011), which was found to be a useful adjunct to pharmacological treatment in mental health 
settings and is of relatively low cost (Daley, 2002).  Studies which explore non-
pharmacological interventions are of particular interest to nurses, because if they are proven 
to be effective, they can be readily incorporated into the nursing management of patients with 
delirium.  They are also useful because they can be investigated without the concomitant  risk 
of adverse effects such as side effects or serious complications, anaphylactic shock for 
example, that can occur with pharmacological interventions (Cancer Research UK, 2015).   
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There remains limited information from randomised controlled trials of pharmacological 
agents to guide practice in evidence-based neuroleptic administration to cancer and palliative 
care patients (Bush and Bruera 2009).  Further research is needed to determine efficacious 
and safe drugs and dosages for the different delirium subtypes and aetiologies, as well as the 
role of nonpharmacological and environment management strategies in improving improve 
the comprehensive multifaceted management of this distressing syndrome (Bush and Bruera 
2009). 
With regard to the implications of  the findings for clinical practice it is important to consider 
options available to alleviate the distressing symptoms of delirium. Although treatments 
unlicensed for use in delirium such as aripiprazole and olanzapine cannot be introduced, 
interventions including exercise therapy could be considered.  Also the findings suggest that 
initiating discussions with doctors and pharmacists about the potential of opioid rotation is 
worthy of further  exploration. In addition practicing in accordance with current guidelines 
for the care and treatment of delirium, including the provision of aides to orientation (for 
example having clocks and calendars visible in clinical areas), should remain a priority of 
care (NICE 2010). 
 
Limitations   
As with any literature review this one has limitations.  For example,  unpublished or 'grey' 
literature was not included which has the potential to introduce publication bias, in that 
journals tend to favour articles which report positive results, leading to over-representation of 
significant findings (Cullinan, 2005; Polit and Beck, 2014).  Also in view of the type of 
interventions used in the treatment of delirium the nature of the studies reported varied, an 
integrated approach was taken because a meta-analysis was not possible.  
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Conclusion  
Delirium is a poorly understood condition which is frequently experienced by patients with 
advanced cancer, however there is limited knowledge of its pathophysiology, particularly of 
its subtypes.  The findings from the seven studies examined in this review do not provide a 
conclusive evidence base for the treatment of delirium for patients with advanced cancer, 
although the interventions seemed to have some impact in terms of reducing the severity or 
the duration of the delirium.  
However despite the lack of evidence on which to make definitive recommendations about 
treatment and care the current gap in knowledge has been identified, and there appear to be 
some promising areas for further research.  More work is needed to build understanding of 
the pathophysiology of delirium in patients with advanced cancer and once this is more 
widely understood there can be more informed research into its treatment.  Ideally this should 
take the form of Randomised Controlled Trials that can take account of confounding factors 
including age, co-treatments and cancer diagnosis (stage and tumour site) so that the effect of 
these factors can be analysed, so the true reason for delirium resolution can be identified.  
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Table 1: Symptoms of delirium by subtype. 
 
Delirium Subtype Symptoms 
Hyperactive Restlessness 
Agitation 
Hallucinations 
Delusions 
Hypoactive Lethargy 
Minimal spontaneous movement  
Slow in responding to questions  
Thought process abnormality 
Mixed A combination of hyperactive and hypoactive 
symptoms. 
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Table 2: Research Question Formulation, PIO 
Population Patients with advanced cancer 
Interventions Pharmacological and non-pharmacological treatments of 
delirium  
Outcome The management of delirium; whether the interventions 
improve, worsen or result in no change to delirium symptoms.  
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Table 3: Database Search Terms 
Population Population Intervention Outcome  
Oncology  Supportive  Treatment  Deliri* 
Cancer  “end of life”  Management   
Neoplasms   Palliative Therapeutics  “acute confusion”  
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Table 4: Inclusion and exclusion criteria and rationale 
Inclusion Criteria  Rationale   
Patients with advanced cancer must 
make up the full or partial sample 
group  
The research question focuses on advanced cancer patients, 
studies on those wither without cancer or cancer that is not 
advanced  
Primary research    Less chance of bias than with secondary research.  
Treatment of delirium must be the 
main focus of the article  
The article must focus on treatment of delirium (treatment can 
be pharmacological or non-pharmacological) rather than 
prevention to address the research question 
Exclusion Criteria   Rationale   
Studies published before the year 2000 The studies are less likely to be relevant to todays practice  
Secondary research    More chance of bias  
Case Reports  The lack of generalisability was viewed as too great as the 
cases were often very complex.  
Unpublished/grey literature  The research r is novice and has limited time to search for 
data  
Studies not published in English  The researcher is novice and only speaks fluent English, so 
does not have the time or resources to translate the articles.   
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Additional records identified 
through hand searching  
(n = 1) 
Records to be screened using title 
and abstract after duplicate 
removal  
(n = 479) 
Duplicates excluded  
(n = 69) 
Full-text articles assessed 
for eligibility  
(n = 27) Full-text articles excluded: 
Focusing on prevention 
rather than treatment n = 
12 
Patients did not have 
advanced cancer n = 5 
Case studies – n= 2  
Conference paper n = 1  
Studies included in 
literature review  
(n=7) 
Records excluded on basis of title 
and abstract (n = 452) 
Figure 1: PRISMA (adapted from Moher et al, 2009) 
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Table 5: Summary of Papers 
Abbreviations; 
MDAS = Memorial Delirium Assessment Scale     CAM = Confusion Assessment Method  ± = standard deviation  EG = Exercise Group 
MMSE = Mini-Mental State Examination.          T1 = Time 1; baseline measurement  TD = Terminal Delirium   NG = Non-exercise group  
DOS =Delirium Observation Screening Scale        T3 = Time 3; 4-7 days after intervention  N = number of participants                     CPB = celiac plexus block 
ANOVA = Analysis of variance   
 
Paper Design Sample & Setting Intervention Delirium Screening 
tool(s) 
Are tools 
reliable? 
Analysis Results Conclusion 
Boettger and 
Breitbart, 2011 
Open Label 
Naturally Assigned  
prospective 
N = 21 
46.7% had advanced cancer 
Memorial Sloan-Kettering 
Cancer Centre – US  
Aripiprazole MDAS Yes Freidman P < 0.001 mean 
MDAS T1 = 18.0, mean MDAS T3 
= 8.3 
Aripiprazole may be safe and effective in 
treating delirium. 
Moryl et al, 2005 Open Label, 
prospective 
N = 20 Advanced cancer 
patients. Tertiary cancer 
palliative care hospital -US 
Methadone ‘switch’ MDAS Yes None ‘Average’ MDAS. Improved from 
23.6 to 10.6 
A switch to methadone may be considered 
before sedation 
Morita et al, 2005 Open Label 
Prospective 
N = 21 
Palliative Care patients, 
morphine induced delirium 7 
palliative care units - Japan 
Opioid Rotation; 
morphine to 
fentanyl.  
MDAS (Japanese 
version). Omitted 
items 
Original – 
yes 
Modified - 
no  
Freidman P < 0.001.  
Mean MDAS decreased from 14 
at T1 to 3.6 at T3  
Opioid Rotation; morphine to fentanyl may 
be effective in alleviating morphine induced 
delirium 
Tatematsu et al, 
2011 
Open- label 
Retrospective 
N = 48, EG = 17  
NG = 31. Prognosis  
< 6 months’ survival in EG = 
35.5%; NG=41.9%. Kyoto 
University Hospital – Japan 
Exercise therapy CAM  Yes  Students t test P < 0.036. Antipsychotic dose 
lower in EG (2.198mg) than NG 
(5.533mg).  
Exercise therapy could be as an 
environmental intervention for delirium 
Arai et al, 2013 Open-label 
Prospective CPB 
group,  
N = 36 
Control Group N = 17 
CPB Group N = 19.  
Pancreatic cancer. TD. 
Palliative-care team - Japan 
Neuroleptic Celiac 
Plexus Block  
DOS Yes Unclear P < 0.003. Duration of TD lower 
in CPB than control (1.8 ± 2.9 vs 
10.4 ± 7.5 days respectively). 
Duration of TD significantly less in patients 
who underwent CPB 
Gagnon et al, 
2005.  
Open-label 
Prospective  
N= 14 hypoactive delirium, 
advanced cancer. Montreal 
General Hospital – Canada.  
Methylphenidate 
hydrochloride 
MMSE Yes Wilcoxon 
signed rank 
test  
P<0.001. Pre-treatment MMSE 
mean=20.9 ± 4.9, stable 
treatment MMSE 
mean=27.8±2.4 
Hypoactive delirium with no known 
aetiology may be improved by 
methylphenidate  
Breitbart et al, 
2002 
Open-Label, 
prospective 
N = 79 
Stage:  terminal = 5%,.  
Memorial Sloan-Kettering 
Cancer - US 
Olanzapine MDAS Yes ANOVA MDAS score improved from a 
mean of 19.85 to 10.78, P = 
0.001. Subtype can affect 
outcome. 76% delirium 
resolution. 
Study begins to demonstrate the efﬁcacy 
and safety of olanzapine for use in the 
management of delirium among 
hospitalized medically ill patients 
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Figure 2 - Critical Appraisal Tool  
Abstract  Are key elements included? Are the Aims 
clearly stated?  
Literature Review Is the literature review up to date? 
Does the literature review establish a focus for 
the study due to a gap in knowledge? 
Method: Research Design Was the most rigorous possible deign used?  
Was bias minimised? 
Were the researchers blinded?  
Were the participants randomised? 
Population and sample Was the population identified and described?  
Was the best possible sampling design used to 
enhance the samples representativeness? 
Was the sample size adequate?  
Was sample bias present? 
Was there a control group?  
Were the inclusion/exclusion criteria stated?  
Data collection and Measurement Are the tools used adequately described and 
was it properly implemented? 
Does the report provide evidence that the data 
collection methods yielded data high on 
reliability and validity?  
Was data collected in a manner that minimised 
bias? 
Procedures If there was an intervention was it clearly 
described and properly implemented?  
Did most participants allocated to the 
intervention group receive it?  
Results: Data Analysis Were appropriate statistical methods used?  
Was p < 0.05? 
Did the analysis control for confounding 
variables?  
Findings/Conclusions Was information about statistical significance 
presented? 
Are limitations identified and discussed? 
Are the results generalizable?  
Does the researcher discuss the results in 
context of the previous literature?   
Does the researcher suggest implications for 
practice and further research?  
 
Adapted from  
Polit D.F., and Beck C.T., 2014. Essentials of Nursing Research: Appraising Evidence for Nursing 
Practice 8
th
 edition. London:  Wolters Kluwer Health/Lippincott Williams & Wilkins  
And  
Hek G., and Moule P., 2006. Making sense of research; an introduction for health and social care 
practitioners. 3
rd
 edition. London; SAGE publication ltd. 
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Table 6: Statistical tests used 
 
Article Data Normal 
Distribution 
Type of Data  Statistical Test 
Used 
Was the test 
appropriate? 
Moryl, 2005 Change in 
MDAS score 
No Interval None Used N/A 
Morita, 2005 Change in 
MDAS score 
No Interval Friedman Yes 
Tatematsu, 
2010 
Difference in 
antipsychotic 
dose 
Unclear Ratio Students t test Unclear 
Arai et al, 
2013 
Duration of 
terminal 
delirium 
No Interval  Unclear Unclear  
Boettger and 
Breitbart, 
2011 
Change in 
MDAS score 
No Interval Friedman  Yes 
Gagnon, 2005 Change in 
MMSE score 
No Interval Matched-paired 
Wilcoxon 
signed rank test 
Yes 
Breitbart, 
2002.  
Change in 
MDAS score 
Yes  Interval ANOVA Yes 
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Table 7 - Results of the Quality Appraisal 
  
Article Design 
(n/5) 
Sample/Sampling 
(n/5) 
Tools 
(n/5) 
Analysis 
(n/5) 
Overall 
Quality 
(n/20) 
Moryl et al, 2005 1 2 5 0 9 
Morita et al, 2005 1 2 4 4 11 
Tatematsu et al, 2011 2 2 2 2 8 
Arai et al, 2013 2 2 4 2 10 
Boettger and Breitbart, 
2011 
1 2 5 3 11 
Gangon et al, 2005 1 2 4 4 11 
Breitbart et al, 2002. 3 3 5 4 15 
Key: 0 (very poor) 5 (excellent) 
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